AWM
AllSquare Wealth Management’s CRISPR Therapeutics CRSP Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $12.3K | Hold |
253
| – | – | 0.01% | 361 |
|
2025
Q1 | $8.61K | Hold |
253
| – | – | 0.01% | 393 |
|
2024
Q4 | $9.96K | Sell |
253
-56
| -18% | -$2.2K | 0.01% | 378 |
|
2024
Q3 | $14.5K | Hold |
309
| – | – | 0.01% | 342 |
|
2024
Q2 | $16.7K | Hold |
309
| – | – | 0.01% | 322 |
|
2024
Q1 | $21.1K | Hold |
309
| – | – | 0.01% | 295 |
|
2023
Q4 | $19.3K | Hold |
309
| – | – | 0.01% | 302 |
|
2023
Q3 | $14K | Sell |
309
-400
| -56% | -$18.2K | 0.01% | 337 |
|
2023
Q2 | $45.8K | Hold |
709
| – | – | 0.03% | 219 |
|
2023
Q1 | $32.1K | Hold |
709
| – | – | 0.02% | 260 |
|
2022
Q4 | $28.8K | Hold |
709
| – | – | 0.02% | 257 |
|
2022
Q3 | $46K | Hold |
709
| – | – | 0.03% | 195 |
|
2022
Q2 | $43K | Hold |
709
| – | – | 0.03% | 214 |
|
2022
Q1 | $45K | Hold |
709
| – | – | 0.03% | 237 |
|
2021
Q4 | $54K | Sell |
709
-19
| -3% | -$1.45K | 0.03% | 212 |
|
2021
Q3 | $81K | Hold |
728
| – | – | 0.05% | 174 |
|
2021
Q2 | $118K | Sell |
728
-106
| -13% | -$17.2K | 0.07% | 138 |
|
2021
Q1 | $102K | Buy |
834
+86
| +11% | +$10.5K | 0.06% | 146 |
|
2020
Q4 | $115K | Buy |
748
+65
| +10% | +$9.99K | 0.08% | 123 |
|
2020
Q3 | $57K | Hold |
683
| – | – | 0.04% | 177 |
|
2020
Q2 | $50K | Buy |
683
+300
| +78% | +$22K | 0.04% | 178 |
|
2020
Q1 | $16K | Hold |
383
| – | – | 0.01% | 259 |
|
2019
Q4 | $23K | Sell |
383
-100
| -21% | -$6.01K | 0.02% | 251 |
|
2019
Q3 | $20K | Buy |
483
+28
| +6% | +$1.16K | 0.01% | 257 |
|
2019
Q2 | $21K | Hold |
455
| – | – | 0.02% | 258 |
|
2019
Q1 | $16K | Buy |
455
+425
| +1,417% | +$14.9K | 0.01% | 273 |
|
2018
Q4 | $1K | Hold |
30
| – | – | ﹤0.01% | 436 |
|
2018
Q3 | $1K | Hold |
30
| – | – | ﹤0.01% | 455 |
|
2018
Q2 | $2K | Hold |
30
| – | – | ﹤0.01% | 445 |
|
2018
Q1 | $1K | Sell |
30
-30
| -50% | -$1K | ﹤0.01% | 378 |
|
2017
Q4 | $1K | Hold |
60
| – | – | ﹤0.01% | 370 |
|
2017
Q3 | $1K | Buy |
+60
| New | +$1K | ﹤0.01% | 348 |
|